Pancreatic cancer patients who were obese up to 20 years before receiving a cancer diagnosis had more than double the risk of dying compared with those who weighed less before diagnosis, according to a study in the Journal of Clinical Oncology. The analysis of data from the Nurses' Health Study and the Health Professionals Follow-Up Study also found that greater prediagnostic BMI was associated with increased likelihood of advanced-stage disease at diagnosis.

Related Summaries